ACIP Supports Lowering Age for Pneumococcal Vaccination to 50 from 65 Years
October 24, 2024

The expanded recommendation includes shots from Merck (PCV21) and Pfizer (PCV20), and could be a "practice-changing milestone," one executive said.

New Data on Renal Protective Benefits of Sotagliflozin Will be Presented at Kidney Week 2024
October 23, 2024

In a post hoc analysis of the SCORED trial, investigators observed positive renal protection with sotagliflozin across a spectrum of baseline kidney function and glycemic control.

Effects of Common Analgesic Medications on Sleep: A Topical Review
October 23, 2024

Findings from a recent review highlight the impact of common analgesic medications on sleep patterns in people with chronic pain.

Make Early Alzheimer Disease Medications Accessible to All, Now
October 23, 2024

FDA-approved early Alzheimer medications should be covered by Medicare and other insurers and made immediately available to all those who will benefit.

FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions
October 23, 2024

Pfizer announced the FDA approval on October 22 that makes Abrysvo now the RSV immunization with the broadest indication for adults, the company said.

COVID-19 Raises Risk of MACE up to 3 Years Later: Daily Dose
October 23, 2024

Your daily dose of the clinical news you may have missed.

FDA Updates Flublok Label with Safety Data for Pregnant Individuals
October 23, 2024

The safety data used to update the Flublok label is from a study of more than 48 000 pregnant women across multiple flu seasons, according to Sanofi.

Beer, Cider Linked to Higher Risk of Gout: Daily Dose
October 22, 2024

Your daily dose of the clinical news you may have missed.

Similar Rates of FIT Completion Support Initiating CRC Screening at Age 45: New Research
October 22, 2024

Nearly 40% of adults aged 45 to 50 years completed a fecal immunochemical test within 3 months, according to a large retrospective study.

Why is Atopic Dermatitis Prevalence Rising? Dermatologist Mona Shahriani, MD, Parses the Trends
October 22, 2024

Shahriari, assistant clinical professor of dermatology at Yale University School of Medicine, says greater understanding of the condition has expanded the population for the diagnosis.